What koji protein is and where it comes from
Koji protein is the protein-rich biomass of Aspergillus oryzae, the koji mould that has been used for centuries to ferment soybeans, rice and other substrates into miso, soy sauce and sake. In this newer use the fungus is not a starter culture but the product itself, grown for its mycelium, which is eaten as a meat-like protein.
The organism has a strong food pedigree. A review describes A. oryzae as a filamentous micro-fungus used for centuries in fermented foods in many countries, with a secretory system that releases large amounts of enzymes. FDA records it as a production organism in GRAS notices, and a Japanese strain is even regarded as the national fungus.
Two production routes are used. Submerged fermentation grows mycelium in a liquid medium in a bioreactor, giving wet biomass that can be pressed into patties. Solid-state fermentation grows the fungus on cooked grains or legumes, producing a whole food in which mould and substrate stay together, as in traditional koji and tempeh.
Both routes sit between the plant and the microbial worlds. The product contains protein, fibre, fat and cell wall polysaccharides, and its nutritional profile depends on the substrate. For that reason koji protein is evaluated as a whole-food ingredient, not as an isolate like pea protein, and sold as a biomass or paste.
Koji protein mycelium composition and nutrition
Protein content in submerged koji biomass is moderate. A pilot study at an airlift bioreactor grew Aspergillus oryzae on oat flour and obtained 6 g per litre of dry biomass with 37 percent protein on a dry weight basis. The authors made burger patties from the washed biomass without further processing.
Other fungal mycelia give a feel for the range. A review reports about 42.5 percent protein for Hericium erinaceus mycelium and 28.4 to 35.7 percent for submerged Pleurotus ostreatus and Lentinula edodes mycelia, while commercially cultivated basidiomycete mycelia showed PDCAAS values from 0.93 to 1.20. These are other species, so they set expectations but do not describe koji.
Fungal protein carries two nutritional issues. First, cell walls rich in chitin and glucans can limit digestibility. Second, microbial biomass has higher nucleic acid levels than plant or animal protein, and purines convert to uric acid, so nucleic acid reduction is part of process design. Suppliers should therefore document RNA content and digestibility.
Fermentation can also improve a plant matrix. Studies of fava bean flour fermented with Aspergillus oryzae and Rhizopus oligosporus showed lower phytic acid, tannins and chymotrypsin inhibitors, and A. oryzae eliminated saponins completely. In koji-style solid-state products, the mould therefore changes both the protein and the antinutrients of the substrate.
Safety, mycotoxins and regulation
Strain control is central to safety. Wild-type A. oryzae has the genetic potential to make several mycotoxins, including aflatoxins, cyclopiazonic acid and 3-nitropropionic acid. A recent strain lineage developed for alternative protein production was reported to lack this capacity because of large deletions, including the 3-NPA biosynthesis genes, which shows that exclusion is technically feasible.
Domesticated koji strains have a long history of safe use, but a history in miso does not automatically cover bulk consumption of biomass. Regulators look at the strain, substrate, process and exposure. For a protein ingredient, a supplier should supply mycotoxin test results, strain identification and a description of the growth medium for each lot.
In the United States, FDA closed GRAS Notice No. 829 on 9 December 2019 for powdered Aspergillus oryzae grown with added minerals, at up to 250 mg per serving, with a no-questions letter. That notice is for a mineral-carrying powder, not a bulk protein, and a search of the inventory for koji returns no records.
In the EU, a review notes that commercialisation of single-cell proteins remains product-specific, not governed by a harmonised framework, and that protein from filamentous fungi grown as biomass is assessed case by case. Companies should plan for a safety dossier that covers the strain, the process, nucleic acids, mycotoxins and allergenicity.
Functionality, flavour and processing
Koji biomass is valued for texture and savoury flavour more than for solubility. As a washed mycelial mass, it has a fibrous, meaty bite from the hyphal network and holds water well, so it can form patties with minimal processing. Dried or milled forms disperse as a coarse, fibrous powder with low solubility.
Flavour is the main selling point. Fungal biomass tends to taste savoury and umami, and koji has an association with fermented foods that consumers recognise. In the burger study, the taste and texture of minimally processed patties appealed to some participants and not to others, which suggests that seasoning and fat remain important design variables.
Processing choices shape quality. Heat treatment inactivates the organism and reduces microbial load, washing removes medium residues, and pressing sets moisture. Mild cooking preserves fibre, while extrusion or forming can change texture. Because nucleic acids matter, some processes use controlled heat steps to lower RNA, with a need to balance this against texture.
Substrate matters as much as strain. Oat flour gave 37 percent protein in one study, while other substrates, including food-industry by-products, have been used to increase protein and polysaccharide content in A. oryzae biomass. Suppliers should state the substrate, since it affects allergen status, flavour, sustainability claims and cost in every contract.
Uses in food products
Meat alternatives are the leading use. A review of fermented meat analogues lists koji alongside mycoprotein and yeast in commercial products such as turkey-style, salami-style, ham-style and bacon-style plant-based items from one brand, where koji is part of a fermented protein base blended with fibres and fats. This shows its role as a structural ingredient in blends.
Whole-food koji products are also made on cereals and legumes. Koji and tempeh made on rice with Aspergillus oryzae and Rhizopus oligosporus kept in vitro protein digestibility close to 81 percent, with no significant change compared with the unfermented control. These products serve as seasoning bases, fermented foods and protein-rich foods.
Koji biomass fits next to other fungal proteins. Mycoprotein from Fusarium has a long regulatory record, and yeast protein comes from a unicellular fungus. Developers choose between them by flavour, texture, nucleic acid content and authorisation, and sometimes combine two fungal ingredients in one product in a single recipe when needed.
Supply is young. Producers range from startups with pilot reactors to ingredient companies that run solid-state koji for seasonings. Buyers evaluating suppliers should ask for strain identity, mycotoxin screening, nucleic acid and digestibility data, allergen statements, the regulatory pathway in each market and the capacity of the fermentation plant to deliver consistent biomass.
Koji protein compared with other fungal and plant proteins
Compared with mycoprotein, koji protein has a younger evidence base but a closer link to traditional foods and a savoury flavour that suits fermented applications. Mycoprotein has a longer record in the market and in regulation. The comparison with soy is explored in mycoprotein vs soy protein and weaker data.
Compared with plant isolates, koji biomass is a minimally processed whole-cell ingredient, with lower protein concentration but a built-in fibrous texture. A practical formula uses koji for the meaty structure and flavour, and adds a plant protein or fat for protein density, juiciness and cost, while managing nucleic acids and allergen labelling.